Letter from the Editor

Contributed by:

Taren Grom, Editor

NOTE: The content below contains the first few paragraphs of the printed article and the titles of the sidebars and boxes, if applicable.

Creating a Vision for the Future

PV0315_TarenGromInnovation, from the Latin word innovatio, is the action or process of innovating.  The definition of innovation varies throughout the industry. But one thing is clear: innovation should not be confused with invention. In this month’s special issue, we explore the concept of innovation  — the value it can bring to an organization, what’s needed to develop a culture of innovation, the barriers that prevent organizations from being innovative, advances in science and technology, as well as what it takes to make innovation sustainable. We also touch on financing issues, ways to incentivize innovation, hubs of excellence, and innovative companies.

By no means is this issue exhaustive in its coverage; we fully recognize that the innovation revolution is an ever-churning machine and we are just scratching the surface. And we look forward to hearing from you on what we missed.

When thinking about how to define innovation, Shideh Sedgh Bina, cof-ounding partner of Insigniam, sums it up nicely: innovation is about generating something novel that creates new value for the enterprise.

Mike Rea, CEO of IDEA Pharma, concurs that innovation is about delivering value, and from his perspective it’s about delivering value to patients.

“In our industry, innovation is essentially what companies can bring to patients,” he explains. “A lot of people talk about innovation, but it’s unclear what they mean, and I think in many cases, what they mean is invention. There’s a lot of inventiveness in our industry, but this doesn’t always deliver value.”

There is a revolution brewing, and companies of all types and sizes are looking to engage in a meaningful way to disrupt the status quo. However, disruption requires vision and a commitment from senior leadership to want to change.

I had the opportunity to speak recently about the importance of vision with Kathy Giusti, founder of the Multiple Myeloma Research Foundation, who was also ranked No. 19 on Fortune magazine’s Worlds’ 50 Greatest Leaders, and in 2011, she was named to the TIME 100 List of the world’s most influential people, as well as  being a PharmaVOICE 100 honoree. She believes that for some leaders vision comes easy — it’s part of their DNA, and for others it may take a mentor to push them to think strategically and in a visionary way. Do you have the vision to be a change agent for your company to move the industry forward?

Ms. Guisti will join Mr. Rea, as well as Craig Lipset, head of clinical innovation, Pfizer, Melinda Richter, head, Johnson & Johnson Innovation JLABS, and moderator Amir Kalali M.D., head, Neuroscience Center of Excellence, Quintiles, in an executive panel at the PharmaVOICE 100 Celebration in September to discuss how to create a vision for the future of the life-sciences industry through innovation and inspired leadership. We look forward to seeing you there. In the meantime, enjoy this special issue and we encourage you to start to think about how you can “be the change that you wish to see in the world.”

Taren Grom
Editor

~~~~~~~~~~~~~~~~~~~~~~~~~

Their word…PV0416_TheirWord

Denise Myshko
Managing Editor

Life-sciences companies are taking cues — hackathons, prizes, and challenges — from other industries as a way to spur innovation.

Robin Robinson
Senior Editor

Of the many constraints that stall innovation, a fear-based culture can be the first to cripple a corporation.

Kim Ribbink
Features Editor

The drive to improve health outcomes is spurring innovative approaches across the globe.

~~~~~~~~~~~~~~~~~~~~~~~~~

Masthead

Volume 16 • Number 4
Publisher    Lisa Banket
Editor    Taren Grom
Creative Director    Marah Walsh

Managing Editor
Denise Myshko

Senior Editor
Robin Robinson

features Editor
Kim Ribbink

Design Associate
Ariel Medel

Director of Sales
Cathy Tracy

National Account Manager
Suzanne Besse

Webcast Network Producer
Daniel Limbach

Circulation Assistant
Kathy Deiuliis

Copyright 2016
by PharmaLinx LLC, Titusville, NJ
Printed in the U.S.A.
Volume Sixteen, Number Four

PharmaVoice (ISSN: 1932961X) is published monthly except joint issues in July/Aug. and Nov./Dec., by ­Pharma­­Linx LLC, P.O. Box 327, Titusville, NJ 08560. ­Periodicals postage paid at Titusville, NJ 08560 and additional mailing offices.

Postmaster: Send address changes to PharmaVoice, P.O. Box 292345, Kettering, OH 45429-0345.

PharmaVoice Coverage and Distribution:
Domestic subscriptions are available at $190 for one year (10 issues). Foreign subscriptions: 10 issues US$360. Contact PharmaVoice at P.O. Box 327, Titusville, NJ 08560. Call us at 609.730.0196 or FAX your order to 609.730.0197.

Contributions: PharmaVoice is not responsible for unsolicited contributions of any type. Unless otherwise agreed in writing, PharmaVoice retains all rights on material published in PharmaVoice for a period of six months after publication and reprint rights after that period expires. E-mail: tgrom@pharmavoice.com.

Change of address: Please allow six weeks for a change of address. Send your new address along with your subscription label to PharmaVoice, P.O. Box 292345, Kettering, OH 45429-0345. Call us at 800.607.4410 or FAX your change to 937.890.0221. E-mail: mwalsh@pharmavoice.com.

Important notice: The post office will not forward copies of this magazine. PharmaVoice is not responsible for replacing undelivered copies due to lack of or late notification of address change.

Advertising in PharmaVoice: To advertise in Pharma­­Voice please contact our Advertising ­Department at P.O. Box 327, Titusville, NJ 08560, or ­telephone us at 609.730.0196. E-mail: lbanket@pharmavoice.com.

 

 

Posted in:

Post a Comment

You must be logged in to post a Comment.

FEEDBACK